MedPath

Fullhope Biomedical Co.,Ltd

Fullhope Biomedical Co.,Ltd logo
🇨🇳China
Ownership
Private
Established
2012-01-01
Employees
11
Market Cap
-
Website
http://www.fhb.com.tw

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Dendritic Killer Cell-based Immunotherapy for Solid Tumors

Phase 1
Conditions
Hepatocellular Carcinoma
Neoplasm Metastasis
Colorectal Neoplasms
First Posted Date
2016-08-30
Last Posted Date
2016-08-30
Lead Sponsor
FullHope Biomedical Co., Ltd.
Target Recruit Count
18
Registration Number
NCT02882659

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.